Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
23873 studies found for:    ( NOT NOTEXT ) [FIRST-RECEIVED-RESULTS-DATE]
Show Display Options
Rank Status Study
21 Completed
Has Results
Novel Portable Diagnostic Device for Automatic Detection of Relative Afferent Pupillary Defect
Conditions: Multiple Sclerosis;   Glaucoma
Interventions: Device: O-Glass;   Other: Swinging Flashlight Test
22 Completed
Has Results
Examining Rehabilitation Training Methods
Conditions: Guided Training;   Directed Training
Interventions: Behavioral: Guided Training;   Behavioral: Directed Training
23 Completed
Has Results
Indocyanine Green (ICG) and SPY Imaging for Assessment of Burn Healing
Condition: Burns
Interventions: Device: ICG/SPY;   Drug: Antibiotic Ointment
24 Completed
Has Results
Intelligent Pain Management System for Assessing Pain in Cancer Patients
Conditions: Pain;   Neoplasms
Intervention: Device: Intelligent Pain Management System
25 Completed
Has Results
Efficacy and Safety of Peg-Interferon Alpha-2a Plus Ribavirin in Genotype 1 Chronic Hepatitis C Participants Co-Infected With Human Immunodeficiency Virus
Condition: Hepatitis C, Chronic
Interventions: Drug: Peg-Interferon Alpha-2A;   Drug: Ribavirin
26 Completed
Has Results
CO-OPerative Training for Stroke Rehabilitation
Conditions: CO-OP;   Attention Control
Interventions: Behavioral: CO-OP;   Behavioral: Attention Control
27 Completed
Has Results
Long Term Follow-up Study to Assess Durability of Sustained Virologic Response in Alisporivir-treated Hepatitis C Patients
Condition: Hepatitis C
Intervention: Drug: Alisporivir
28 Completed
Has Results
Potential of Stannous Fluoride Toothpaste to Reduce Gum Disease
Condition: Gingivitis
Interventions: Drug: Stannous Fluoride;   Drug: Sodium Monofluorophosphate
29 Completed
Has Results
Bioequivalence Study of Two Nitisinone Formulations Compared to Orfadin
Condition: Hereditary Tyrosinemia, Type I
Interventions: Drug: Nitisinone;   Drug: Nitisinone 10 mg Tablet High Compritol;   Drug: Orfadin
30 Completed
Has Results
Bioequivalence Study of Two Oral Nitisinone Formulations to Treat Hereditary Tyrosinemia (HT-1)
Condition: Hereditary Tyrosinemia, Type I
Interventions: Drug: Nitisinone;   Drug: Nitisinone Baked Tablet;   Drug: Orfadin
31 Completed
Has Results
Bioavailability Food-Effect Study of an Oral Nitisinone Formulation to Treat Hereditary Tyrosinemia (HT-1)
Condition: Hereditary Tyrosinemia, Type I
Intervention: Drug: Nitisinone
32 Completed
Has Results
A Study of Herceptin (Trastuzumab) in Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Advanced and/or Metastatic Breast Cancer
Condition: Breast Cancer
Interventions: Drug: Xeloda;   Drug: Taxotere;   Drug: Herceptin
33 Completed
Has Results
Impact of Mindfulness Based Stress Reduction on Anxiety, Depression and QOL in Women With Intrauterine Adhesion.
Condition: Asherman Syndrome
Intervention: Other: Mindfulness Based Stress Reduction
34 Completed
Has Results
A Human Factor Study To Asses The Usability And Feasibility Of The Peritron+ During Intended Use
Condition: Urology
Intervention: Device: Peritron+
35 Completed
Has Results
Intention to Prescribe/Take OAC Depending on the Number of Risk Diagrams , and Period for the Estimation of the Risk.
Conditions: Atrial Fibrillation;   Stroke
Intervention: Other: decision aid
36 Completed
Has Results
Mask Leak With Nasal Cannula in Noninvasive Positive Pressure Ventilation
Condition: Mechanical Ventilation Pressure High
Interventions: Device: Nasal cannula;   Device: Non-invasive positive pressure ventilation
37 Completed
Has Results
Effectiveness of Respiratory Physiotherapy in Children With Neuromuscular Disease
Condition: Neuromuscular Diseases
Interventions: Other: RESPIRATORY PHYSIOTHERAPY;   Other: USUAL THERAPIES
38 Terminated
Has Results
Comparison of Ibandronate - Zoledronate Regarding Nephrotoxicity in Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Drug: Ibandronate;   Drug: Zoledronate
39 Completed
Has Results
Expanded Access Study With Peginterferon Alfa-2a (Pegasys) in Participants With Chronic Myelogenous Leukemia (CML)
Condition: Myelogenous Leukemia, Chronic
Intervention: Drug: Peginterferon alfa-2a
40 Completed
Has Results
A Study of Pegylated Interferon (PEG-IFN) Alfa-2a (Pegasys) in Participants With Chronic Hepatitis D (CHD)
Condition: Hepatitis D, Chronic
Intervention: Drug: Pegylated Interferon (PEG-IFN) alfa-2a

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.